compounded glp 1 risks New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Cheap GLP1s Online? Think Twice!

Understanding Insulin-like Growth Factor-1 Insulin-like growth factor-1 (IGF-1), formerly known as somatomedin or somatomedin C, has a single chain 70-amino acid polypeptide cross-linked by 3 disulfide bridges. Although IGF-1 provides several benefits similar to insulin such as lower blood sugar levels, the key difference is that insulin mediates mainly a metabolic response, whereas IGF-1 mediates growth-promoting effects (Source)

Both approaches are reasonable given the limited data on optimal timing

These mice were injected with the drugs i.p

Useful for transport, whether you are picking up your medication or traveling with semaglutide or traveling with tirzepatide